259 related articles for article (PubMed ID: 11154697)
1. Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.
Gerlach LO; Skerlj RT; Bridger GJ; Schwartz TW
J Biol Chem; 2001 Apr; 276(17):14153-60. PubMed ID: 11154697
[TBL] [Abstract][Full Text] [Related]
2. Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor.
Gerlach LO; Jakobsen JS; Jensen KP; Rosenkilde MR; Skerlj RT; Ryde U; Bridger GJ; Schwartz TW
Biochemistry; 2003 Jan; 42(3):710-7. PubMed ID: 12534283
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor.
Rosenkilde MM; Gerlach LO; Hatse S; Skerlj RT; Schols D; Bridger GJ; Schwartz TW
J Biol Chem; 2007 Sep; 282(37):27354-27365. PubMed ID: 17599916
[TBL] [Abstract][Full Text] [Related]
4. Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.
Hatse S; Princen K; Gerlach LO; Bridger G; Henson G; De Clercq E; Schwartz TW; Schols D
Mol Pharmacol; 2001 Jul; 60(1):164-73. PubMed ID: 11408611
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor.
Rosenkilde MM; Gerlach LO; Jakobsen JS; Skerlj RT; Bridger GJ; Schwartz TW
J Biol Chem; 2004 Jan; 279(4):3033-41. PubMed ID: 14585837
[TBL] [Abstract][Full Text] [Related]
6. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
[TBL] [Abstract][Full Text] [Related]
7. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities.
Brelot A; Heveker N; Montes M; Alizon M
J Biol Chem; 2000 Aug; 275(31):23736-44. PubMed ID: 10825158
[TBL] [Abstract][Full Text] [Related]
8. CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection.
Klasse PJ; Rosenkilde MM; Signoret N; Pelchen-Matthews A; Schwartz TW; Marsh M
J Virol; 1999 Sep; 73(9):7453-66. PubMed ID: 10438835
[TBL] [Abstract][Full Text] [Related]
9. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
[TBL] [Abstract][Full Text] [Related]
10. Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor.
Esté JA; Cabrera C; De Clercq E; Struyf S; Van Damme J; Bridger G; Skerlj RT; Abrams MJ; Henson G; Gutierrez A; Clotet B; Schols D
Mol Pharmacol; 1999 Jan; 55(1):67-73. PubMed ID: 9882699
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.
Zhou N; Luo Z; Luo J; Liu D; Hall JW; Pomerantz RJ; Huang Z
J Biol Chem; 2001 Nov; 276(46):42826-33. PubMed ID: 11551942
[TBL] [Abstract][Full Text] [Related]
12. Importance of receptor flexibility in binding of cyclam compounds to the chemokine receptor CXCR4.
Lam AR; Bhattacharya S; Patel K; Hall SE; Mao A; Vaidehi N
J Chem Inf Model; 2011 Jan; 51(1):139-47. PubMed ID: 21158459
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1alpha: implications for development of selective CXCR4 antagonists.
Gupta SK; Pillarisetti K; Thomas RA; Aiyar N
Immunol Lett; 2001 Aug; 78(1):29-34. PubMed ID: 11470148
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel non-cyclam polynitrogenated CXCR4 coreceptor inhibitors.
Pettersson S; Pérez-Nueno VI; Ros-Blanco L; Puig de La Bellacasa R; Rabal MO; Batllori X; Clotet B; Clotet-Codina I; Armand-Ugón M; Esté J; Borrell JI; Teixidó J
ChemMedChem; 2008 Oct; 3(10):1549-57. PubMed ID: 18671217
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
16. Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100.
Labrosse B; Brelot A; Heveker N; Sol N; Schols D; De Clercq E; Alizon M
J Virol; 1998 Aug; 72(8):6381-8. PubMed ID: 9658078
[TBL] [Abstract][Full Text] [Related]
17. Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.
Egberink HF; De Clercq E; Van Vliet AL; Balzarini J; Bridger GJ; Henson G; Horzinek MC; Schols D
J Virol; 1999 Aug; 73(8):6346-52. PubMed ID: 10400726
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4.
Schols D; Struyf S; Van Damme J; Esté JA; Henson G; De Clercq E
J Exp Med; 1997 Oct; 186(8):1383-8. PubMed ID: 9334378
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides.
Heveker N; Montes M; Germeroth L; Amara A; Trautmann A; Alizon M; Schneider-Mergener J
Curr Biol; 1998 Mar; 8(7):369-76. PubMed ID: 9545196
[TBL] [Abstract][Full Text] [Related]
20. In vitro reconstitution and preparative purification of complexes between the chemokine receptor CXCR4 and its ligands SDF-1alpha, gp120-CD4 and AMD3100.
Dukkipati A; Vaclavikova J; Waghray D; Garcia KC
Protein Expr Purif; 2006 Dec; 50(2):203-14. PubMed ID: 16962791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
